SUVZ (Suvanza) Net Margin %: -38,157.14% (As of Mar. 2003)


What is Suvanza Net Margin %?

Suvanza SUVZ Net Margin % is -38,157.14% as of Mar. 2003.

Net margin is calculated as Net Income divided by its Revenue. Suvanza's Net Income for the three months ended in Mar. 2003 was $-2.67 Mil. Suvanza's Revenue for the three months ended in Mar. 2003 was $0.01 Mil. Therefore, Suvanza's net margin for the quarter that ended in Mar. 2003 was -38,157.14%.

The historical rank and industry rank for Suvanza's Net Margin % or its related term are showing as below:


SUVZ's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Suvanza  (OTCPK:SUVZ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Suvanza Net Margin % Related Terms


Suvanza Net Margin % Historical Data

* Premium members only.

The historical data trend for Suvanza's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suvanza Net Margin % Chart

Suvanza Annual Data
Trend Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -2,012.83 -946,800.00 -40,905.88 0.00

Suvanza Quarterly Data
Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -38,157.14

SUVZ vs ADYNF, FPMI, GLAG: Net Margin % Comparison

For the Biotechnology subindustry, Suvanza's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suvanza Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suvanza's Net Margin % distribution charts can be found below:

* The bar in red indicates where Suvanza's Net Margin % falls into.



Suvanza Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Suvanza's Net Margin for the fiscal year that ended in Dec. 2002 is calculated as

Net Margin=Net Income (A: Dec. 2002 )/Revenue (A: Dec. 2002 )
=-16.835/0
= %

Suvanza's Net Margin for the quarter that ended in Mar. 2003 is calculated as

Net Margin=Net Income (Q: Mar. 2003 )/Revenue (Q: Mar. 2003 )
=-2.671/0.007
=-38,157.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -38,157.14% mean?
Suvanza (SUVZ) has a Net Margin % of -38,157.14% as of Mar. 2003. Net margin is the ratio of total net income to net sales. View historical data on Suvanza and its competitors.
Is Suvanza's Net Margin % too high?
Suvanza's current Net Margin % is -38,157.14%.
How does Suvanza's Net Margin % compare to ADYNF and FPMI?
Suvanza's Net Margin % of -38,157.14% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Suvanza and its competitors. Suvanza's current Net Margin % is -38,157.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suvanza stock overvalued right now?
Suvanza (SUVZ) has a current Net Margin % of -38,157.14%. The current Net Margin % is -38,157.14%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Suvanza (SUVZ), the current Net Margin % is -38,157.14% as of Mar. 2003. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suvanza Business Description

Address 5401 Collins Avenue, Suite CU-9A, Miami Beach, FL, USA, 33140
Suvanza is a biotechnology company which develops products for skin, hair, and nails diseases.